SOPHiA GENETICS to Present at the J.P. Morgan 2023 Healthcare Conference
January 04 2023 - 4:02PM
Business Wire
SOPHiA GENETICS SA (NASDAQ: SOPH) today announced that Dr. Jurgi
Camblong, Chief Executive Officer and Co-Founder, is scheduled to
present at the J.P. Morgan 2023 Healthcare Conference on Tuesday,
January 10, 2023, at 8:15 a.m. PST in San Francisco.
Live, listen-only webcasts of this presentation can be accessed
by visiting the Investors section of the SOPHiA GENETICS website at
ir.sophiagenetics.com. A replay of the webcast will be available
shortly after the conclusion of the presentation and archived on
the company's website for two weeks following the presentation.
About SOPHiA GENETICS
SOPHiA GENETICS (NASDAQ: SOPH) is a cloud-native software
company in the healthcare space dedicated to establishing the
practice of data-driven medicine as the standard of care and for
life sciences research. It is the creator of the SOPHiA DDM ™
Platform, a software platform capable of analyzing data and
generating insights from complex multimodal data sets and different
diagnostic modalities. The SOPHiA DDM ™ Platform and related
solutions, products, and services are currently used by a broad
network of hospital, laboratory, and biopharma institutions
globally. For more information, please visit
http://www.SOPHiAGENETICS.com or follow SOPHiA GENETICS on Twitter
(@SOPHiAGENETICS).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230104005924/en/
SOPHiA GENETICS Media Contact: Don Granese pr@sophiagenetics.com
or Investor Contact: Katherine Bailon, ir@sophiagenetics.com
Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart
From Jul 2023 to Jul 2024